Atea Pharmaceuticals, Inc. (AVIR) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$5.76
Day's range
$6.18

Atea Pharmaceuticals Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FMR LLC 02/17/2026 9.68 M $34.55 M   66.23% 12.24%
BLACKROCK, INC. 02/12/2026 8.49 M $30.31 M   0.38% 10.74%
BML CAPITAL MANAGEMENT, LLC 02/03/2026 7.49 M $26.74 M   0.21% 9.47%
TANG CAPITAL MANAGEMENT LLC 02/17/2026 4.81 M $17.19 M   -0.24% 6.09%
VANGUARD GROUP INC 01/29/2026 4.23 M $15.09 M   -10.24% 5.35%
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC 02/17/2026 2.49 M $8.87 M   0.00% 3.14%
GEODE CAPITAL MANAGEMENT, LLC 02/09/2026 1.84 M $6.57 M   -3.09% 2.33%
STATE STREET CORP 02/13/2026 1.78 M $6.37 M   0.03% 2.26%
DIMENSIONAL FUND ADVISORS LP 02/12/2026 1.37 M $4.90 M   -10.82% 1.74%
JPMORGAN CHASE & CO 02/11/2026 1.35 M $4.81 M   118.58% 1.71%
ACADIAN ASSET MANAGEMENT LLC 02/10/2026 1.30 M $4.65 M   34.45% 1.65%
RENAISSANCE TECHNOLOGIES LLC 02/12/2026 1.19 M $4.24 M   -3.21% 1.50%
TWO SIGMA ADVISERS, LP 02/17/2026 1.06 M $3.78 M   33.09% 1.34%
TWO SIGMA INVESTMENTS, LP 02/17/2026 745.42 K $2.66 M   58.16% 0.94%
MILLENNIUM MANAGEMENT LLC 02/17/2026 698.16 K $2.49 M   43.29% 0.88%
MORGAN STANLEY 02/13/2026 656.08 K $2.34 M   45.61% 0.83%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/13/2026 607.79 K $2.17 M   -2.75% 0.77%
NORTHERN TRUST CORP 02/17/2026 560.22 K $2.00 M   -12.24% 0.71%
GOLDMAN SACHS GROUP INC 03/25/2026 472.52 K $1.69 M   38.92% 0.60%
D. E. SHAW & CO., INC. 02/17/2026 464.79 K $1.66 M   27.42% 0.59%
PEAPOD LANE CAPITAL LLC 01/28/2026 435.02 K $1.55 M   -4.85% 0.55%
CM MANAGEMENT, LLC 02/02/2026 355.00 K $1.27 M   -29.00% 0.45%
BANQUE PICTET & CIE SA 01/16/2026 345.08 K $1.23 M   0.00% 0.44%
JANE STREET GROUP, LLC 02/12/2026 250.71 K $895.02 K   30.51% 0.32%
BARCLAYS PLC 02/13/2026 242.99 K $867.47 K   0.63% 0.31%
WELLINGTON MANAGEMENT GROUP LLP 02/17/2026 242.84 K $866.94 K   -7.59% 0.31%
HSBC HOLDINGS PLC 03/20/2026 241.27 K $855.32 K   16.92% 0.31%
NUVEEN, LLC 02/12/2026 240.59 K $858.90 K   -5.96% 0.30%
BANK OF NEW YORK MELLON CORP 02/10/2026 198.46 K $708.51 K   -4.35% 0.25%
UBS GROUP AG 01/29/2026 192.54 K $687.37 K   88.38% 0.24%
OPALEYE MANAGEMENT INC. 04/13/2026 179.82 K $641.94 K   100.00% 0.23%
AUOUR INVESTMENTS LLC 01/12/2026 177.00 K $631.89 K   0.00% 0.22%
AMERICAN CENTURY COMPANIES INC 02/13/2026 170.33 K $608.06 K   -6.25% 0.22%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 02/17/2026 148.40 K $529.79 K   3.70% 0.19%
BANK OF AMERICA CORP /DE/ 02/17/2026 135.79 K $484.78 K   -56.70% 0.17%
ALLIANCEBERNSTEIN L.P. 02/17/2026 127.82 K $456.32 K   0.00% 0.16%
MARSHALL WACE, LLP 02/13/2026 113.59 K $405.50 K   30.47% 0.14%
STRS OHIO 02/02/2026 113.50 K $405.20 K   0.00% 0.14%
PRICE T ROWE ASSOCIATES INC /MD/ 02/17/2026 97.32 K $348.00 K   -0.22% 0.12%
RHUMBLINE ADVISERS 02/13/2026 93.98 K $335.48 K   -17.28% 0.12%
STATE OF WISCONSIN INVESTMENT BOARD 02/17/2026 91.25 K $325.75 K   -14.70% 0.12%
ALDEBARAN CAPITAL, LLC 02/12/2026 90.53 K $323.19 K   100.00% 0.11%
INVESCO LTD. 02/19/2026 87.91 K $313.83 K   -29.33% 0.11%
RANGELEY CAPITAL, LLC 02/17/2026 80.00 K $285.60 K   0.00% 0.10%
WELLS FARGO & COMPANY/MN 02/13/2026 79.79 K $284.87 K   35.54% 0.10%
LOS ANGELES CAPITAL MANAGEMENT LLC 02/11/2026 77.30 K $252.78 K   0.00% 0.10%
MACQUARIE MANAGEMENT HOLDINGS, INC. 02/17/2026 70.00 K $250.00 K   100.00% 0.09%
ALPS ADVISORS INC 02/12/2026 64.15 K $229.03 K   74.56% 0.08%
POINT72 ASSET MANAGEMENT, L.P. 02/17/2026 63.91 K $228.14 K   100.00% 0.08%
EVERSOURCE WEALTH ADVISORS, LLC 02/06/2026 56.98 K $203.43 K   -62.23% 0.07%

Atea Pharmaceuticals Inc institutional Ownership - FAQ's

During the previous two years, 147 institutional investors and hedge funds held shares of Atea Pharmaceuticals Inc. The most heavily invested institutionals were:

BML Capital Management, LLC: 7.06 M

DIMENSIONAL FUND ADVISORS LP: 1.26 M

VANGUARD FIDUCIARY TRUST CO: 484,705

JANE STREET GROUP, LLC: 418,296

CM Management, LLC: 355,000

BANQUE PICTET & CIE SA: 345,077

72.11% of Atea Pharmaceuticals Inc stock is owned by institutional investors.

Institutional investors have bought a total of 68.08 M shares in the last 24 months. This purchase volume represents approximately $418.66 M in transactions.